Vida Ventures, which describes itself as a next-generation life sciences venture firm announced on 8/1/19 the closing of Vida Ventures II, LLC (“Vida II”),... read more
Vida Ventures, which describes itself as a next-generation life sciences venture firm announced on 8/1/19 the closing of Vida Ventures II, LLC (“Vida II”),... read more
Vapotherm recently filed the paperwork for a new $57 Million offering. The company's HI-VNI technology provides maskless high velocity nasal insufflation for patients in respiratory distress or... read more
In a previous article (found here), we discussed the findings of a 2016 study that... read more
On July 11, 2019, the U.S. Department of Justice announced that Reckitt Benckiser Group PLC agreed to pay $1.4 billion to resolve possible criminal and civil liability related to allegations... read more
Life science investment firm, Medicxi, announced on 7/19/19 that it has closed its Medicxi III fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. The... read more